Loading clinical trials...
Loading clinical trials...
Phase II Study of Topical Rapamycin to Erase Angiofibromas in TSC-Multicenter Evaluation of a Novel Therapy
Conditions
Interventions
Placebo
Rapamycin
+1 more
Locations
10
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
UCLA Mattel Children's Hospital
Los Angeles, California, United States
Jack & Julia Center for TSC at Oakland Children's Hospital & Research Center
Oakland, California, United States
Kennedy Krieger Institute
Baltimore, Maryland, United States
Herscot Center for Adults and Children with TSC Massachusetts General Hospital
Boston, Massachusetts, United States
Clinic Without Walls
Saint Paul, Minnesota, United States
Start Date
May 1, 2012
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2014
Last Updated
October 26, 2020
NCT03050268
NCT00001975
NCT07369505
NCT06139172
NCT06330350
NCT06764602
Lead Sponsor
The University of Texas Health Science Center, Houston
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions